Shareholders Equity (Quarterly) Chart

View Shareholders Equity (Quarterly) for YECO.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Shareholders Equity (Quarterly) Chart
Start Trial

Historical Shareholders Equity (Quarterly) Data

View and export this data back to 2015. Start Trial.
Date Value
September 30, 2025 -2.07M
June 30, 2025 -2.022M
March 31, 2025 -1.975M
December 31, 2024 -1.982M
September 30, 2024 -1.989M
June 30, 2024 -2.073M
March 31, 2024 -1.881M
December 31, 2023 -1.683M
September 30, 2023 -1.448M
June 30, 2023 -3.418M
March 31, 2023 -3.236M
December 31, 2022 -13.83M
September 30, 2022 -2.959M
June 30, 2022 6.259M
March 31, 2022 7.105M
December 31, 2021 7.216M
September 30, 2021 7.323M
June 30, 2021 7.545M
March 31, 2021 7.453M
December 31, 2020 7.611M
Date Value
September 30, 2020 1.060M
June 30, 2020 1.100M
March 31, 2020 1.151M
December 31, 2019 1.457M
September 30, 2019 1.228M
June 30, 2019 1.298M
March 31, 2019 1.349M
December 31, 2018 1.542M
September 30, 2018 2.603M
December 31, 2017
September 30, 2017
June 30, 2017
March 31, 2017
December 31, 2016 6.036M
September 30, 2016 8.586M
June 30, 2016 11.27M
March 31, 2016 72.92M
December 31, 2015 69.46M
September 30, 2015 68.75M

Shareholders' Equity Definition

Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.

Read full definition.

Shareholders Equity (Quarterly) Range, Past 5 Years

View Shareholders Equity (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Shareholders Equity (Quarterly) Benchmarks

View Shareholders Equity (Quarterly) Benchmarks
Start Trial
Arrowhead Pharmaceuticals, Inc. 465.53M
Athersys, Inc. --
Oncolytics Biotech, Inc. -6.167M
Sangamo Therapeutics, Inc. -18.96M
Sarepta Therapeutics, Inc. 1.528B

Shareholders Equity (Quarterly) Related Metrics